Related Experiment Videos

Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins

P M Chaudhary1, A Jasmin, M T Eby

  • 1Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas, TX 75235-8593, USA.

Oncogene
|October 19, 1999
PubMed

Insights

Viral FLIPs (vFLIPs) proteins, containing Death Effector Domains (DEDs), not only block cell death but also modulate the NF-kappaB pathway by interacting with key signaling proteins. This interaction may influence viral infection progression.

Area of Science:

  • Molecular Biology
  • Virology
  • Immunology

Background:

  • Death Effector Domains (DEDs) mediate Caspase 8 recruitment to the death-inducing signaling complex (DISC).
  • Viral proteins with DEDs, known as viral FLICE inhibitory proteins (vFLIPs), can inhibit receptor-mediated cell death.

Purpose of the Study:

  • To investigate the broader functional role of vFLIPs beyond cell death inhibition.
  • To explore the interaction of vFLIPs with signaling proteins involved in the NF-kappaB pathway.

Main Methods:

  • Experimental investigation of vFLIPs' interaction with signaling molecules.
  • Analysis of vFLIPs' impact on the NF-kappaB pathway.

Main Results:

  • vFLIPs physically interact with TRAFs, RIP, NIK, and IKKs.
  • vFLIPs demonstrate the ability to modulate the NF-kappaB signaling pathway.

Conclusions:

  • Viral proteins containing DEDs (vFLIPs) possess functions beyond blocking apoptosis.
  • vFLIPs' modulation of the NF-kappaB pathway may be significant in the pathogenesis of viral infections.

Related Concept Videos